As of Oct 23
| -0.37 / -6.31%|
The 7 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 9.00, with a high estimate of 16.00 and a low estimate of 3.00. The median estimate represents a +63.93% increase from the last price of 5.49.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.